Changes related to "Vindesine (Eldisine)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 15:15, 25 June 2018
   
Page name:

25 June 2018

 m   14:47  Non-small cell lung cancer‎ (diff | hist) . . (+1,041). . Jwarner (talk | contribs)

23 June 2018

 m   17:31  Non-small cell lung cancer‎ (diff | hist) . . (+242). . Jwarner (talk | contribs) (Erlotinib monotherapy {{#subobject:c3c726|Regimen=1}})

22 June 2018

 m   22:32  Diffuse large B-cell lymphoma‎‎ (2 changes | history) . . (-927). . [Jwarner‎ (2×)]
 m    22:32 (cur | prev) . . (+49). . Jwarner (talk | contribs) (R-CHOP-14 {{#subobject:fc3bde|Regimen=1}})
 m    19:16 (cur | prev) . . (-976). . Jwarner (talk | contribs) (R-CVP {{#subobject:1b5df7|Regimen=1}})
     16:33  Non-small cell lung cancer‎‎ (9 changes | history) . . (+18,555). . [Jwarner‎ (9×)]
 m    16:33 (cur | prev) . . (+1,480). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:75f589|Regimen=1}})
 m    15:10 (cur | prev) . . (+1,741). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:75f589|Regimen=1}})
      15:05 (cur | prev) . . (+4,616). . Jwarner (talk | contribs) (Advanced or metastatic disease, first-line)
      14:46 (cur | prev) . . (+2,156). . Jwarner (talk | contribs) (Maintenance after first-line therapy)
      14:38 (cur | prev) . . (+5,171). . Jwarner (talk | contribs) (Carboplatin & Docetaxel {{#subobject:bdce59|Regimen=1}})
 m    13:54 (cur | prev) . . (+3,369). . Jwarner (talk | contribs) (Carboplatin, Paclitaxel, Bevacizumab {{#subobject:1c2c25|Regimen=1}})
 m    13:42 (cur | prev) . . (+67). . Jwarner (talk | contribs)
 m    13:19 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Carboplatin & nab-Paclitaxel {{#subobject:413b7d|Regimen=1}})
 m    13:17 (cur | prev) . . (-49). . Jwarner (talk | contribs)
 m   15:45  Post-transplant lymphoproliferative disorder‎ (diff | hist) . . (+14). . Jwarner (talk | contribs) (References)

20 June 2018

 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:33  CNS lymphoma‎ (diff | hist) . . (+49). . Jwarner (talk | contribs) (Upfront therapy, non-randomized or retrospective data)

19 June 2018

 m   17:36  HIV-associated lymphoma‎‎ (2 changes | history) . . (+195). . [Jwarner‎ (2×)]
 m    17:36 (cur | prev) . . (+2,688). . Jwarner (talk | contribs) (Upfront therapy)
 m    17:35 (cur | prev) . . (-2,493). . Jwarner (talk | contribs) (DR-COP {{#subobject:ec091e|Regimen=1}})
 m   17:05  CNS lymphoma‎ (diff | hist) . . (-171). . Jwarner (talk | contribs)

17 June 2018

 m   21:46  Non-small cell lung cancer‎‎ (3 changes | history) . . (+1,659). . [Jwarner‎ (3×)]
 m    21:46 (cur | prev) . . (+813). . Jwarner (talk | contribs) (Cisplatin & Gemcitabine {{#subobject:fb3ee0|Regimen=1}})
 m    20:49 (cur | prev) . . (+846). . Jwarner (talk | contribs) (Carboplatin & Paclitaxel {{#subobject:c5fbdf|Regimen=1}})
 m    20:45 (cur | prev) . . (0). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:75f589|Regimen=1}})